Even as potential Alzheimer’s drugs failed, researchers with fresh approaches struggled to get funded and to get studies published in top journals.
The pediatrician and philanthropist insists the goal the couple has set — to “cure, prevent, or manage all diseases” by the year 2100 — is a realistic one.
Australia's medical research and development industry punches above its weight, but much of its intellectual property is being sold overseas.
"How can the presence of one identifiable variant justify the costs and delays of mandatory FDA oversight?"
Students in the Princeton Entrepreneurship Club have formed a team called Alimtas BioVentures, which performs due diligence and develops pitches for technology developed through Princeton ...
Aerie nabs former Allergan exec Senchnya as VP of medical affairs; Novartis' Basson takes CMO role at Boston; Hannah tapped as CMO at CytomX.
It was a busy week for biotech quarterly and annual reports. Here’s a look at some of the top stories including Bristol-Myers Squibb, AbbVie, GSK, Merck and more.
In honor of Black History Month, BioSpace chose to highlight 10 African American leaders in the life sciences, individuals who have prominent roles in the life sciences and ...